Monday, June 15, 2026

Doctor Sentenced to 4 Years for Illegally Selling Etomidate: A Shocking Case of Medical Misconduct

A South Korean doctor received a four-year prison sentence for illegally profiting $940,000 by administering etomidate for sleep treatments.

Experts Say It’s Time to Beat North Korea at Its Own Propaganda Game

Experts suggest using North Korea's logic to criticize its troop deployment to Russia, emphasizing accountability and psychological warfare.

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

Tag: Digmbio

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

New Hope for Solid Tumors? Korean Biotech Starts Phase 1 Trial of Targeted Drug

Digmbio secures 12 billion KRW for clinical trials of cancer drug DM5167 and advances treatment for degenerative brain diseases.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.